Company Profile
IQVIA Stock Price, News & Catalysts
- Ticker:
- IQV
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
260.72 USD (-3.02%)
Close
Last updated: October 1, 2026
30.1B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, IQV closed down 3.02% at $260.72. No new same-company headline was identified in the current news window.
Company overview
Life Sciences Data and Services Company
IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers. Its model combines global execution capabilities with large healthcare datasets, analytics, and technology.
Research and Development Solutions
Research and Development Solutions supports clinical trials from study design and site selection through patient recruitment, monitoring, data management, and regulatory submission. The business operates globally and generates substantial contracted backlog from multiyear development programs.
Commercial Solutions
Commercial Solutions provides market data, real-world evidence, consulting, technology, patient support, and commercial engagement services. Customers use these offerings to assess markets, plan launches, optimize field operations, and measure product performance.
Connected Intelligence Platform
IQVIA Connected Intelligence links proprietary data, healthcare-grade AI, advanced analytics, and domain expertise. The platform is designed to convert fragmented clinical and commercial information into decisions across drug development and commercialization.
Global Scale and Therapeutic Expertise
IQVIA operates in more than 100 countries with expertise spanning clinical operations, data science, technology, and healthcare markets. This scale allows the company to support multinational trials and commercial programs while adapting to local regulatory and privacy requirements.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of IQVIA (IQV)?
IQVIA (IQV) most recently closed at 260.72 USD, a -3.02% move versus the previous session.
What is the market cap of IQVIA (IQV)?
IQVIA currently has a market capitalization of 30.1B USD on BioPharmSignal.
What does IQVIA do?
Life Sciences Data and Services Company IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers. Its model combines global execution capabilities with large healthcare datasets, analytics, and technology. Research and Development...
On which exchange is IQV stock listed?
IQVIA (IQV) is associated with NYSE, United States, Biopharma.
What is Life?
Life Sciences Data and Services Company IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers.
Which conditions is IQVIA targeting with Life?
Life Sciences Data and Services Company IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers. Its model combines global execution capabilities with large healthcare datasets, analytics, and technology. Research and Development...
What is Sciences?
Life Sciences Data and Services Company IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers.
What is Data?
Life Sciences Data and Services Company IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers.